DLL3-targeting antibodies and uses thereof
MYPI2025006824A0Undetermined Publication Date: 2021-01-11TRI INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025006824
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-07-11
- Filing Date
- 2020-07-08
- Publication Date
- 2021-01-11
Abstract
The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to delta-like protein 3 (DLL3). The antibodies of the present technology are useful in methods for detecting and treating a DLL3-associated cancer in a subject in need thereof. FIG. 1
Need to check novelty before this filing date? Find Prior Art
